About Ehave

About Ehave

Recent News and Insights

CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease

By | MegaTeam, Press Releases
The CHILD-BRIGHT Mega Team game is an innovative video game-based cognitive intervention that aims to improve executive functions in children with brain-based developmental disabilities. The CHILD-BRIGHT Network, a Canadian patient-oriented research network focused on pediatric brain-based developmental disorders, and Ehave,...
Read More

Aequus and Ehave Enter into Collaboration Agreement for Comprehensive Patient Data Management in Clinical Trials of Medical Cannabis

By | Medical Cannabis, Press Releases
Ehave’s Bioinformatics Platform Technology to Be Used to Evaluate Aequus’ Products in Multiple Neurological Disorders Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products,...
Read More

Revive Therapeutics and Ehave Enter into Patient Research Data Collaboration Agreement for Medical Cannabis Liver Disease Program

By | Medical Cannabis, Press Releases
Revive Therapeutics Ltd. ("Revive") (TSX VENTURE: RVV) (OTCQB: RVVTF), a company focused on the research, development and commercialization of novel cannabinoid solutions, and Ehave, Inc. (“Ehave”) (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation...
Read More

SUBSCRIBE TO RECEIVE NEWS AND INSIGHTS BY EMAIL